BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//New Jersey Alliance for Clinical and Translational Science - ECPv6.15.14//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:New Jersey Alliance for Clinical and Translational Science
X-ORIGINAL-URL:https://njacts.rbhs.rutgers.edu
X-WR-CALDESC:Events for New Jersey Alliance for Clinical and Translational Science
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20190101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200701
DTEND;VALUE=DATE:20200702
DTSTAMP:20260410T042232
CREATED:20200611T211844Z
LAST-MODIFIED:20200611T211844Z
UID:14595-1593561600-1593647999@njacts.rbhs.rutgers.edu
SUMMARY:NJ ACTS Opportunity for Early Stage Investors
DESCRIPTION:NJ ACTS Opportunity for Early Stage Investors– The NCCIH has issued a Notice of Special Interest [NOT-AT-20-010]\, which invites CTSA-funded Institutional Career Development (KL2) awardees to apply for an administrative supplement to fund one or more additional KL2 Scholars. Letters of Intent due today. Read More.
URL:https://njacts.rbhs.rutgers.edu/event/nj-acts-opportunity-for-early-stage-investors/
END:VEVENT
END:VCALENDAR